SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is trending ahead of its Q4 earnings report, with community focus on potential Phase 3 advancement for its oral VK2735 obesity drug, a move expected to accelerate its development. This optimism is reinforced by recent FDA actions against compounded GLP-1s, highlighting the value of VKTX's legitimate and "best-in-class" pipeline in the booming metabolic market.

Churchill Capital Corp. X is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded by Michael Klein on January 4, 2024 and is headquartered in New York, NY.

Churchill Capital Corp X - Ordinary Shares - Class A

Churchill Capital Corp X 

Churchill Capital Corp X (CCCX) is actively discussed as its merger with quantum technology company Infleqtion approaches, with a shareholder vote scheduled for February 12 and a ticker change to INFQ expected soon after. The community is bullish, citing Infleqtion's recent NASA and DOE contracts and strong commercial pipeline as reasons it's undervalued compared to its quantum sector peers.

Salesforce, Inc. engages in the design and development of cloud-based enterprise software for customer relationship management. Its solutions include sales force automation, customer service and support, marketing automation, digital commerce, community management, collaboration, industry-specific solutions, and salesforce platform. The firm also provides guidance, support, training, and advisory services. The company was founded by Marc Russell Benioff and Parker Harris in 1999 and is headquartered in San Francisco, CA.

Salesforce Inc

Salesforce is facing a significant sell-off, reflecting broad market fears that generative AI will disrupt traditional enterprise software and pushing the stock to multi-year lows. Despite widespread panic, a strong contingent of investors highlights the company's robust free cash flow, deep undervaluation, and strategic AI integrations, viewing the current decline as a prime buying opportunity.

NovoCure Ltd. is an oncology company which engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. Its platform is called the Tumor Treating Field which uses electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. The company was founded by Yoram Palti in 2000 and is headquartered in St. Helier, Jersey.

NovoCure Ltd

NovoCure is trending following U.S. FDA approval of its Optune Pax for locally advanced pancreatic cancer, hailed by the community as the first new treatment in three decades to extend survival and improve quality of life, which is driving optimism for a significant rally and substantial market penetration.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

Applovin Corp ($APP) is trending as a major short-seller retracted false allegations and Reuters corrected an erroneous headline, fueling community calls for a significant rebound and questioning market manipulation amidst strong company fundamentals and high volatility.

Fastly, Inc. provides real-time content delivery network services. It offers edge compute, edge delivery, edge security, edge applications like load balancing and image optimization, video on demand, and managed edge delivery. The company was founded by Artur Bergman, Tyler McMullen, Simon Wistow, and Gil Penchina in March 2011 and is headquartered in San Francisco, CA.

Fastly Inc - Ordinary Shares - Class A

Fastly Inc

Fastly Inc. is trending after its robust earnings report, showcasing record revenue, gross margin, and its first profitable fiscal year, signaling a significant financial inflection point. The community is actively discussing the strong 'beat and raise' performance and optimistic guidance, emphasizing AI as a growing tailwind for its edge computing and security business.

Cisco Systems, Inc. engages in the design, manufacture, and sale of Internet Protocol-based networking products and services related to the communications and information technology industry. The firm operates through the following geographical segments: the Americas, EMEA, and APJC. Its products include the following categories: Secure, Agile Networks, Internet for the Future, Collaboration, End-to-End Security, Optimized Application Experiences, and Other Products. The company was founded by Sandra Lerner and Leonard Bosack in 1984 and is headquartered in San Jose, CA.

Cisco Systems, Inc.

Cisco is trending after reporting an earnings and revenue beat, driven by accelerating demand for AI infrastructure orders, leading to raised guidance. The community is debating whether this signals a significant AI growth story, potentially pushing the stock towards previous highs, or if it's an overvalued momentum play with ongoing concerns about gross margin pressures from rising memory-chip costs.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape is trending following an earnings report that highlighted the operational "Eagle Line" and B-sample shipments to OEMs, with community discussion split between excitement for these production milestones and frustration over the continued absence of specific yield data and named commercial partners.

Vertiv Holdings Co. engages in the design, manufacture, and service of critical digital infrastructure technology for data centers, communication networks, and commercial and industrial environments. It also offers power management products, switchgear and busbar products, thermal management products, integrated rack systems, modular solutions, and management systems for monitoring and controlling digital infrastructure. It operates through the following geographical segments: Americas, Asia Pacific, and Europe, Middle East, and Africa (EMEA). The Americas segment offers products and services sold for applications within the data center, communication networks, and commercial and industrial markets in North America and Latin America. The Asia Pacific segment includes products and services sold for applications within the data center, communication networks, and commercial or industrial markets throughout Greater China, Australia and New Zealand, Southeast Asia, and India. The EMEA segment focuses on products and services sold for applications within the data center, communication networks, and commercial and industrial markets in Europe, Middle East, and Africa. The company was founded in 1946 and is headquartered in Columbus, OH.

Vertiv Holdings Co - Ordinary Shares - Class A

Vertiv Holdings Co

Vertiv Holdings (VRT) is surging after reporting strong earnings and an optimistic 2026 outlook, driven by overwhelming demand for its critical power and thermal infrastructure solutions essential for AI data centers. The community is actively discussing VRT's pivotal role in the AI buildout, though some are noting its significant valuation spike.

HubSpot, Inc. engages in cloud-based customer relationship management. Its platform includes marketing, sales, service, operations and content management system, as well as other tools, integrations and native payment solutions. It operates through the following geographical segments: Americas, Europe and Asia Pacific. The company was founded by Brian Patrick Halligan and Dharmesh Shah on April 4, 2005, and is headquartered in Cambridge, MA.

HubSpot Inc

HubSpot is trending after reporting strong financial results and forward guidance, along with announcing a $1 billion share repurchase program. The community is actively debating whether these positive fundamentals and a potential short squeeze can counter prevailing fears of AI disruption and challenges to the company's growth levers within the broader software sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>XTL will acquire NeuroNOS for 19.9% of its issued share capital, $1 million in cash, and milestone-based contingent payments totaling up to $32.5 million. &nbsp;</li><li>NeuroNOS is a biotechnology company eyeing the development of therapeutics for Autism Spectrum Disorder (ASD) and other neurodevelopmental and neurodegenerative disorders.&nbsp;</li><li>NeuroNOS will now serve as XTL's platform for autism and neuro-oncology therapeutics.</li></ul>Shares of Beyond Air, Inc. (XAIR) rallied 149% on Tuesday after XTL Biopharmaceuticals Ltd. (XTLB) announced a deal to acquire a majority stake in its subsidiary NeuroNOS Ltd.Under the deal, IP portfolio company XTL will <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.beyondair.net/news-events/press-releases?i=161064">acquire</a> 85% of NeuroNOS, a biotechnology company eyeing the development of therapeutics for Autism Spectrum Disorder (ASD), and other neurodevelopmental and neurodegenerative disorders.Shares of XTLB gained 51% at the time of writing.<h2 class="st-heading-2">Deal Terms</h2>As part of the deal, XTL will acquire 85% of NeuroNOS for 19.9% of XTL's issued share capital, $1 million in cash, and milestone-based contingent payments totaling up to $32.5 million.XTL noted that NeuroNOS's drug development platform is designed to address the underlying molecular mechanisms driving autism unlike treatments based on behavioral symptoms. NeuroNOS will now serve as XTL's platform for autism and neuro-oncology therapeutics.According to BeyondAir, autism spectrum disorder affects about one in 31 children in the U.S. and has been rising dramatically. No FDA-approved therapies aimed at disease modification exist for the disorder at present.The company also noted that the Trump administration has, in recent times, emphasized support for new medicines aimed at treating autism.“The administration has allocated $50 million in new NIH funding for autism research initiatives. This recognition at the federal level signals a fundamental shift in regulatory priorities and resource allocation toward autism research and treatment development,” BeyondAir said in a statement.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around XAIR and XTLB rose from ‘bullish’ to ‘extremely bullish’ territory over the past 24 hours, while message volume increased from ‘high’ to ‘extremely high’ levels.A Stocktwits user applauded the deal, opining that selling most of the unit will help de-risk Beyond Air’s investment while also creating potential future revenue streams.<stembedurl>https://www.stocktwits.com/stockpro2010/message/641694012</stembedurl><a href="https://stocktwits.com/symbol/XAIR">XAIR stock</a> has fallen 70% this year while <a href="https://stocktwits.com/symbol/XTLB">XTLB</a> dropped 44% in the same period.Read More: <a href="https://stocktwits.com/news-articles/markets/equity/travere-therapeutics-stock-slumps-after-fda-extends-drug-review-timeline-to-april/cmUXhZuR4IK">Travere Therapeutics Stock Slumps After FDA Extends Drug Review Timeline To April: Retail Is Divided On Eventual Approval</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Rising stock market chart on a trading board background.

XAIR Stock More Than Doubled Today — What’s Driving The Rally?

Beyond Air said that IP portfolio company XTL will acquire 85% of its subsidiary NeuroNOS.

Equity

Beyond Air said that IP portfolio company XTL will acquire 85% of its subsidiary NeuroNOS.


CommScope Holding Company Inc. (COMM) witnessed retail sentiment and message volume hit a one-year high on Stocktwits on Monday after the company struck a deal to divest its Connectivity and Cable Solutions (CCS) division to Amphenol Corporation (APH) in an all-cash transaction valued at $10.5 billion.&nbsp;The transaction is slated to close in the first half of 2026, pending shareholder approval and regulatory clearance.&nbsp;<a href="https://stocktwits.com/symbol/COMM">CommScope stock</a> traded over 91% higher by Monday afternoon. Retail sentiment around the stock shifted to ‘extremely bullish’ (98/100) from ‘bullish’ territory the previous day. Message volume jumped to ‘extremely high’ (96/100) from ‘normal’ levels in 24 hours.&nbsp;<figure class="image"><img style="aspect-ratio:953/104;" src="https://news.stocktwits-cdn.com/Screenshot_2025_08_04_135903_png_0a79ce6cc2.webp" alt="COMM’s Sentiment Meter and Message Volume as of 02:00 p.m. ET on Aug. 4, 2025 | Source: Stocktwits" width="953" height="104"><figcaption>COMM’s Sentiment Meter and Message Volume as of 02:00 p.m. ET on Aug. 4, 2025 | Source: Stocktwits</figcaption></figure>A Stocktwits user lauded the buyout.&nbsp;<stembedurl>https://stocktwits.com/ghcb1981/message/623597970</stembedurl>Another user expects the stock to finish above $15, saying ‘Get in while it’s cheap!’<stembedurl>https://stocktwits.com/SvenneKaare/message/623621273</stembedurl>The agreement marks a major reshaping of CommScope’s business portfolio as it focuses on core operations. The company anticipates net proceeds of roughly $10 billion once taxes and fees are accounted for, and a significant portion will go toward paying off all existing debt and redeeming its preferred shares, currently held by The Carlyle Group Inc. (CG).&nbsp;The company noted it will retain some leverage on its remaining operations but expects to hold a substantial cash reserve after the transaction.Once the sale is completed and all financial obligations are settled, CommScope intends to return surplus funds to investors. A dividend distribution is expected within 60 to 90 days of closing, though final details, including the exact payout, will be determined later.The company also reported its second-quarter (Q2) revenue of $1.39 billion, beating the analysts’ consensus estimate of $1.25 billion, as per Fiscal AI data. CommScope stock has gained over 188% year-to-date and over 643% in the past 12 months.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/amazon-s-podcast-bet-falters/chrXAm9Rdcb">Amazon’s Podcast Bet Falters As Job Cuts Loom At Wondery: Report</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

The company logo for Commscope is displayed during the Tech Show at ExCel London on March 12, 2025 in London, England.

CommScope Stock Rockets 91% As Retail Bulls Cheer $10.5B Asset Sale: ‘Get In While It’s Cheap!’

Once the sale is completed and all financial obligations are settled, CommScope intends to return surplus funds to investors. 

XTL Biopharmaceuticals Ltd. engages in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases. Its product pipeline includes hCDR1 and rHuEPO. The company was founded on March 9, 1993 and is headquartered in Ramat Gan, Israel.

X.T.L. Biopharmaceuticals Ltd. - ADR

Beat EPS and revenue

Beat EPS, miss revenue

Miss EPS, beat revenue

Miss EPS and revenue

What do you expect from $COIN earnings on Thursday?

XTLB
XTL Biopharmaceuticals Ltd.

Feed

News

Sentiment

Fundamentals

Info

Latest XTLB News

XTLBXTL Biopharmaceuticals Ltd.